国家自然科学基金(81370855)

作品数:14被引量:76H指数:5
导出分析报告
相关作者:魏强柳良仁朱育春杨璐陈波更多>>
相关机构:四川大学华西医院德阳市人民医院日喀则市人民医院四川大学更多>>
相关期刊:《Precision Clinical Medicine》《现代泌尿外科杂志》《国际泌尿系统杂志》《四川大学学报(医学版)》更多>>
相关主题:RADICAL腹腔镜手术TRACTNEPHROURETERECTOMY更多>>
相关领域:医药卫生更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
泌尿生殖系统炎性肌纤维母细胞瘤的临床病理及预后
《现代泌尿外科杂志》2021年第2期112-115,146,共5页陈波 徐何 郭耀川 郭建兵 柳良仁 魏强 
国家自然科学基金(No.81370855,No.81200551,No.81770756);四川省科技厅基金(No.2015SZ0230,No.2017KJT0034;No.2020YJ0054);四川省卫健委项目(No.18PJ462);成都市科技局项目(No.2018-YF05-00208-SN)。
目的研究泌尿生殖系统炎性肌纤维母细胞瘤(IMT)的临床病理特点及患者预后。方法检索四川大学华西医院的医疗记录电子数据库,纳入2009年5月至2019年1月泌尿生殖系统IMT患者共33例,收集并分析了患者的临床特征、病理特征、治疗及预后等资...
关键词:炎性肌纤维母细胞瘤 泌尿生殖系统 肾脏 膀胱 
去势抵抗性前列腺癌新型内分泌治疗耐药机制研究进展被引量:12
《中华男科学杂志》2021年第2期167-171,共5页陈波(综述) 郭建兵(综述) 柳良仁(审校) 魏强(审校) 
国家自然科学基金(81370855、81200551、81770756);四川省科技厅基金(2015SZ0230)。
前列腺癌是男性泌尿生殖系统最常见的恶性肿瘤之一,雄激素在其发生发展中都扮演着重要角色。经去势治疗(ADT)后绝大多数前列腺癌都会进展成为去势抵抗性前列腺癌(CRPC)。肾上腺来源的雄激素和(或)雄激素受体(AR)的改变(包括AR基因扩增)...
关键词:前列腺癌 去势抵抗性前列腺癌 雄激素受体 雄激素 去势治疗 
Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer被引量:5
《Asian Journal of Andrology》2020年第2期217-221,共5页Kun Jin Shi Qiu Xin-Yang Liao Xiao-Nan Zheng Xiang Tu Lian-Sha Tang Lu Yang Qiang Wei 
This manuscript was supported by the National Key Research and Development Program of China(Grant No.SQ2017YFSF090096);the Prostate Cancer Foundation Young Investigator Award 2013,the National Natural Science Foundation of China(Grant No.81300627,No.81370855,No.81702536,and No.81770756);Programs from Science and Technology Department of Sichuan Province(Grant No.2014JY0219 and No.2017HH0063);Young Investigator Award of Sichuan University 2017.
Biochemical recurrence(BCR)is important for measuring the oncological outcomes of patients who undergo radical prostatectomy(RP).Whether transurethral resection of the prostate(TURP)has negative postoperative effects ...
关键词:BIOCHEMICAL RECURRENCE PROSTATE cancer RADICAL prostatectomy TRANSURETHRAL RESECTION 
Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma
《Asian Journal of Andrology》2020年第2期177-183,共7页Hang Xu Jian-Zhong Ai Ping Tan Tian-Hai Lin Xi Jin Li-Na Gong Hao-Ran Lei Lu Yang Qiang Wei 
This program was supported by the National key Research and Development program of China(Grant No.SQ2017YFSF090096);the Prostate Cancer Foundation Young Investigator Award 2013,the National Natural Science Foundation of China(Grant No.81300627,No.81370855,No.81702536,and No.81770756);Programs from Science and Technology Department of Sichuan Province(Grant No.2018JY0089 and No.2017HH0063);Young Investigator Award of Sichuan University 2017(Grant No.2017SCU04A17).The funders had no role in patient selection,data extraction,statistical analysis or interpretation,writing of this article,or the decision to publish.
This study aimed to further validate the prognostic role of fibrinogen in upper tract urothelial carcinoma(UTUC)in a large Chinese cohort.A total of 703 patients who underwent radical nephroureterectomy were retrospec...
关键词:FIBRINOGEN prognosis RADICAL NEPHROURETERECTOMY upper TRACT UROTHELIAL carcinoma 
Comparative assessment of efficacy and safety of different treatment for de novo overactive bladder children: A systematic review and network meta-analysis
《Asian Journal of Urology》2019年第4期330-338,共9页Shi Qiu Siwei Bi Tianhai Lin Zhuheng Wu Qi’an Jiang Jiwen Geng Liangren Liu Yige Bao Xiang Tu Mingjing He Lu Yang Qiang Wei 
This study was supported by the Prostate Cancer Foundation Young Investigator Award 2013,the National Natural Science Foundation of China(Grant Nos.81300627,81200551,81270841,81460148,81500522 and 81370855);Programs from Science and Technology Department of Sichuan Province(Grant Nos.2013SZ0006 and 2014JY0219);International Cooperation Fund of Sichuan Science and Technology Program(2017HH0063);China Postdoctoral Science Foundation(2017M612971).
Objective:To compare these managements focusing on the efficacy and safety to treat overactive bladder(OAB)in children through network meta-analysis(NMA).Methods:We searched PubMed,Embase,the Cochrane Library Central ...
关键词:Overactive bladder META-ANALYSIS ANTICHOLINERGICS Parasacral transcutaneous electrical nerve stimulation 
Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells被引量:10
《Asian Journal of Andrology》2019年第4期393-399,共7页Yu Fan Lu Yang Qiang Wei Yu Ding Zhuang Tang Ping Tan Tao Lin Duan Guo Shi Qiu 
the National Key Research and Development Program of China (Grant No. SQ2017YFSF090096);National Natural Science Foundation of China (Grant No. 81370855,81770756 and 81300627);Foundation of Science and Technology Department of Sichuan Province (Grant No. 2013SZ0006, 2015SZ0230, 2018JY0089 and 2017HH0063);1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (Grant No. ZY2016104);Youth Researcher Funding of Sichuan University (Grant No. 2017SCU11042 and 2017SCU04A17);Research Funding of Sichuan Health and Family Planning Commission (Grant No. 17PJ159,18PJ434 and 18PJ453).
Prostate inflammation (PI) is closely related to the development and progression of chronic prostatic diseases: benign prostatic hyperplasia and prostate cancer. Toll-like receptor (TLR) 2 has been reported to be asso...
关键词:benign PROSTATIC HYPERPLASIA INFLAMMATION TOLL-LIKE receptor 2 (TLR2) TLR10 
CRPC的治疗靶点及新型药物研究进展被引量:4
《现代泌尿外科杂志》2019年第7期580-584,共5页陈波 曹德宏 陈泽昱 郭建兵 彭珠峰 杨璐 林天海 刘振华 刘承飞 GAO ALLEN C 董强 柳良仁 魏强 
国家自然科学基金(No.81370855、81200551);四川省科技厅基金(No.2015SZ0230、2017KJT0034)
前列腺癌是男性泌尿生殖系统常见的恶性肿瘤之一。目前去势抵抗性前列腺癌(CRPC)患者中位生存期仅12个月,预后极差。尽管去势治疗(ADT)去除了循环中绝大多数雄激素,但其仍然受残留雄激素的影响。本文综述了CYP17A1抑制剂(阿比特龙等)、5...
关键词:去势抵抗性前列腺癌 酶抑制剂 雄激素受体抑制剂 免疫治疗 镭-223 
The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma被引量:9
《Asian Journal of Andrology》2019年第2期163-169,共7页Ping Tan Ming Shi Jie Chen Hang Xu Nan Xie Huan Xu Yong Jiang Jian-Zhong Ai Liang-Ren Liu Lu Yang Qiang Wei 
the National Key Research and Development Program of China(Grant No.SQ2017YFSF090096);the Prostate Cancer Foundation Young Investigator Award 2013,the National Natural Science Foundation of China(Grant No.81300627,81370855,81702536,and 81770756);the Science and Technology Department of Sichuan Province(Grant No.2014JY0219 and 2017HH0063);Young Investigator Award of Sichuan University 2017.The funders had no role in patient selection,data extraction,statistical analysis or interpretation,writing of this article,or the decision to publish.
Cystatin-C(Cys-C)has been reported as a valuable prognostic biomarker in various malignancies.However,its effect on upper tract urothelial carci noma(UTUC)patie nts has not bee n investigated before.Thus,to explore th...
关键词:CYSTATIN-C prognosis RADICAL NEPHROURETERECTOMY upper TRACT UROTHELIAL carcinoma 
Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment被引量:3
《Precision Clinical Medicine》2018年第1期49-56,共8页Ping Tan Ming Shi Li Lai Zhuang Tang Nan Xie Hang Xu Qiang Wei Xiaoyu Zhang Lu Yang Lily Wu 
supported by the National Key Research and Development Program of China(Grant No.SQ2017YFSF090096);the Prostate Cancer Foundation Young Investigator Award 2013;the National Natural Science Foundation of China(Grant No.81300627,81370855,81702536,81770756);Programs from Science and Technology Department of Sichuan Province(Grant No.2018JY0089 and 2017HH0063);Young Investigator Award of Sichuan University 2017.
Chemokines are best known for their abilities of recruiting immune cells and forming lymphoid tissue.Through interactions between chemokines and their receptors,various immune cell subsets are recruited into the tumor...
关键词:CHEMOKINE CXCL13 CXCR5 tumor microenvironment 
腹腔镜经腰腹联合途径行较大肾上腺肿瘤切除的临床研究被引量:5
《四川大学学报(医学版)》2015年第2期336-339,共4页杨璐 高亮 陈勇吉 卜司元 李涛 朱育春 韩平 李响 魏强 范天勇 
国家自然科学青年基金(No.81300627);国家自然科学基金(No.81370855);美国前列腺癌基金(Prostate Cancer Foundation;PCF);四川省科技厅应用基础项目(No.2014JY0219)资助
目的研究腹腔镜新的手术路径——经腰腹联合途径切除较大肾上腺肿瘤的临床安全性和有效性。方法直径≥6.0cm的肾上腺肿瘤分别采用经腹腹腔镜(n=30)和腹腔镜经腰腹联合途径(n=30)行肾上腺肿瘤切除。收集并比较两组间基本资料、手术中数...
关键词:腹腔镜 肾上腺肿瘤 经腰腹联合入路 手术 
检索报告 对象比较 聚类工具 使用帮助 返回顶部